Imaging neurodegeneration in multiple sclerosis
多发性硬化症的神经变性影像学
基本信息
- 批准号:9270631
- 负责人:
- 金额:$ 35.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-01 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAngiographyAnimalsAtrophicAutopsyBackBlood-Retinal BarrierBrainBrain regionClinicalDataDemyelinationsDiseaseDisease ProgressionDropoutEtiologyEvaluationExtravasationEyeFluoresceinFunctional disorderGanglion Cell LayerImageImmuneInflammationInner Nuclear LayerInner Plexiform LayerLesionLinkMagnetic Resonance ImagingMeasuresMediatingMethodsModelingMultiple SclerosisMyelinNerve DegenerationNeurologicNeuronsNuclearOphthalmic examination and evaluationOphthalmologyOptic Nerve TransectionsOptic NeuritisOptical Coherence TomographyOpticsOutcomePathologyPatientsPatternPermeabilityPhenotypePredispositionProcessQuality of lifeRadiology SpecialtyRecruitment ActivityResolutionRetinaRetinalRetinal DegenerationSiteSocietiesStructureSwellingTestingThickThinnessTimeWaxesaxon injurycerebral atrophycohortcostdisabilityexperimental studygray matterimaging biomarkerin vivoinsightmultiple sclerosis patientneuron lossnew technologynoveloptic nerve disorderprematurepublic health relevanceretina outer nuclear layerretinal nerve fiber layertomographywhite matterwhite matter injury
项目摘要
DESCRIPTION (provided by applicant): There is emerging evidence that gray matter (GM) degeneration is common in multiple sclerosis (MS), and more closely linked with disability than white matter (WM) injury. Indeed, WM volumes, as measured by high resolution MRI, wax and wane as a reflection of inflammation, whereas GM atrophy accelerates with time in MS. Whether GM degeneration purely results from WM injury or may also occur as a primary process in MS is unclear. More recently there has been growing evidence that primary neuronal loss in the cortex and retina may occur in MS, independent of demyelination or axonal injury. The retina, although an unmyelinated brain structure, is now recognized to be a frequent site of inflammation, blood-retinal-barrier disruption, and neuronal loss in MS, highlighting the retina as
an opportune site to study the mechanisms by which inflammation directly mediates neurodegeneration in MS, and link these processes back to what is occurring in the brain. However, the interplay between changes in retinal layers over time, and the relationships of these changes with brain-substructure changes in MS remains unclear, and we propose to investigate this in the current application. Herein, we hypothesize that ONL atrophy is the consequence of INL inflammation, and signifies increased susceptibility for global neurodegeneration in MS as a consequence of inflammation. The completion of the experiments outlined in this application will reveal novel insights into the pathobiological mechanisms through which inflammation mediates neurodegeneration in myelinated and unmyelinated regions of the brain in MS. Specifically, we plan to determine if primary neuronal mechanisms of pathology are operative in MS retina, and if this primary neuronopathy is predictive of GM atrophy and the accrual of clinical disability in MS. The results could provide evidence to challenge the paradigm that MS is a myelin dependant disorder, and directly impact present concepts of how to target degeneration and disease progression in MS.
描述(由申请人提供):有新兴的证据表明,灰质(GM)变性在多发性硬化症(MS)中很常见,并且与残疾(WM)损伤更与残疾密切相关。实际上,通过高分辨率MRI,蜡和衰落测量的WM体积作为炎症的反射,而GM萎缩随着MS的时间加速。 GM变性是否纯粹是由于WM损伤引起的还是也可能是MS中的主要过程发生的。最近,越来越多的证据表明,在MS中,皮质和视网膜的原发性神经元丧失可能与脱髓鞘或轴突损伤无关。视网膜虽然是一种不髓鞘的大脑结构,但现在被认为是MS的频繁炎症部位,血液 - 视网膜障碍的破坏和神经元丧失的位置,重点介绍了视网膜
研究炎症直接介导MS中神经退行性的机制的适当位置,并将这些过程链接回大脑中发生的过程。但是,随着时间的推移,视网膜层的变化之间的相互作用与这些变化与MS的变化的关系尚不清楚,我们建议在当前应用中进行调查。在本文中,我们假设ONL萎缩是INL炎症的结果,这表明由于炎症而增加了MS全球神经变性的易感性。该应用程序中概述的实验的完成将揭示对病理学机制的新见解,通过这些见解,炎症介导了MS中大脑的髓鞘和无毛状区域中的神经变性。具体而言,我们计划确定病理学的主要神经元机制在MS视网膜中是否有效,并且该原发性神经病是否可以预测GM萎缩和MS中临床障碍的应计。结果可以提供证据来挑战范式表明MS是一种髓磷脂依赖性疾病,并直接影响了如何靶向MS中的退化和疾病进展的当前概念。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER A CALABRESI其他文献
PETER A CALABRESI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER A CALABRESI', 18)}}的其他基金
Validation of Serum Neurofilament Light Chain as a Prognostic and Monitoring Biomarker in Multiple Sclerosis
血清神经丝轻链作为多发性硬化症预后和监测生物标志物的验证
- 批准号:
10543186 - 财政年份:2020
- 资助金额:
$ 35.44万 - 项目类别:
Validation of Serum Neurofilament Light Chain as a Prognostic and Monitoring Biomarker in Multiple Sclerosis
血清神经丝轻链作为多发性硬化症预后和监测生物标志物的验证
- 批准号:
10322766 - 财政年份:2020
- 资助金额:
$ 35.44万 - 项目类别:
Imaging neurodegeneration in multiple sclerosis
多发性硬化症的影像学神经退行性变
- 批准号:
8482285 - 财政年份:2013
- 资助金额:
$ 35.44万 - 项目类别:
Imaging neurodegeneration in multiple sclerosis
多发性硬化症的影像学神经退行性变
- 批准号:
10330016 - 财政年份:2013
- 资助金额:
$ 35.44万 - 项目类别:
Imaging neurodegeneration in multiple sclerosis
多发性硬化症的神经变性影像学
- 批准号:
8841026 - 财政年份:2013
- 资助金额:
$ 35.44万 - 项目类别:
Imaging neurodegeneration in multiple sclerosis
多发性硬化症的影像学神经退行性变
- 批准号:
9043962 - 财政年份:2013
- 资助金额:
$ 35.44万 - 项目类别:
Selective modulation of thyroid hormone receptors to promote remyelination
选择性调节甲状腺激素受体以促进髓鞘再生
- 批准号:
8426917 - 财政年份:2012
- 资助金额:
$ 35.44万 - 项目类别:
Selective modulation of thyroid hormone receptors to promote remyelination
选择性调节甲状腺激素受体以促进髓鞘再生
- 批准号:
8554391 - 财政年份:2012
- 资助金额:
$ 35.44万 - 项目类别:
MECHANISMS OF NEURODEGENERATION AND STRATEGIES FOR NEUROPROTECTION IN MS
多发性硬化症的神经变性机制和神经保护策略
- 批准号:
7602577 - 财政年份:2007
- 资助金额:
$ 35.44万 - 项目类别:
ANALYSIS OF THE AXONAL DEGENERATION FOLLOWING INFLAMMATORY DEMYELINATION IN MULT
多发性骨髓瘤炎性脱髓鞘后轴突变性的分析
- 批准号:
7604738 - 财政年份:2006
- 资助金额:
$ 35.44万 - 项目类别:
相似国自然基金
基于eNOS功能障碍创建可逆性脑血管收缩综合征(RCVS)小鼠模型的研究
- 批准号:81873753
- 批准年份:2018
- 资助金额:81.0 万元
- 项目类别:面上项目
载基因VEGF165超声微泡造影剂治疗肺动脉高压动物模型的实验研究
- 批准号:81460268
- 批准年份:2014
- 资助金额:46.0 万元
- 项目类别:地区科学基金项目
基于血管内膜超声微泡空蚀的局部可控易损斑块动物模型建立及活体评价方法
- 批准号:31271003
- 批准年份:2012
- 资助金额:15.0 万元
- 项目类别:面上项目
改善年龄老化导致下肢新生血管生成障碍的实验研究
- 批准号:81070257
- 批准年份:2010
- 资助金额:30.0 万元
- 项目类别:面上项目
经外周静脉肝脏超声血管造影剂的研制及其动物实验研究
- 批准号:39470225
- 批准年份:1994
- 资助金额:7.0 万元
- 项目类别:面上项目
相似海外基金
Mechanistic Understanding of Mustard Gas Toxicity in the Retina using a Minipig Model
使用小型猪模型了解芥子气视网膜毒性的机制
- 批准号:
10882080 - 财政年份:2023
- 资助金额:
$ 35.44万 - 项目类别:
Two-for-one Stroke Thrombectomy: A novel Dual DAC to enhance navigability, lumen size, aspiration efficiency, and persistent flow arrest in mechanical thrombectomy
二合一中风血栓切除术:一种新型双 DAC,可增强机械血栓切除术中的导航性、管腔尺寸、抽吸效率和持续流动停止
- 批准号:
10698538 - 财政年份:2023
- 资助金额:
$ 35.44万 - 项目类别:
Magnetic Rotational Exploratory Platform for Coronary Lesions
冠状动脉病变磁旋转探索平台
- 批准号:
10384033 - 财政年份:2022
- 资助金额:
$ 35.44万 - 项目类别:
Spreading Depolarizations and Perfusion in Non-traumatic Spinal Cord Injury
非创伤性脊髓损伤中的扩散去极化和灌注
- 批准号:
10480464 - 财政年份:2022
- 资助金额:
$ 35.44万 - 项目类别:
Spreading Depolarizations and Perfusion in Non-traumatic Spinal Cord Injury
非创伤性脊髓损伤中的扩散去极化和灌注
- 批准号:
10596632 - 财政年份:2022
- 资助金额:
$ 35.44万 - 项目类别: